Edition:
United States

Cardinal Health Inc (CAH.N)

CAH.N on New York Stock Exchange

73.44USD
4:02pm EDT
Change (% chg)

$0.34 (+0.47%)
Prev Close
$73.10
Open
$73.23
Day's High
$73.64
Day's Low
$73.14
Volume
294,418
Avg. Vol
602,363
52-wk High
$85.46
52-wk Low
$62.80

CAH.N

Chart for CAH.N

About

Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear... (more)

Overall

Beta: 0.81
Market Cap(Mil.): $23,091.02
Shares Outstanding(Mil.): 315.88
Dividend: 0.46
Yield (%): 2.53

Financials

  CAH.N Industry Sector
P/E (TTM): 17.45 21.63 41.26
EPS (TTM): 4.19 -- --
ROI: 9.39 9.13 53.05
ROE: 20.15 10.65 60.72

BRIEF-Cardinal Health board approved 3 pct increase in qtrly dividend

* Cardinal Health -board of directors approved a 3 percent increase in company's quarterly dividend from $0.4489 per share to $0.4624 per share Source text for Eikon: Further company coverage:

May 03 2017

BRIEF-Cardinal Health says generic pricing definitely getting better

* Ceo says "experiencing pricing deflation in generics, some heightened reimbursement pressures which affect our customers"-conf call

May 01 2017

Cardinal Health quarterly profit ahead of estimates

Cardinal Health Inc reported a better-than-expected quarterly profit, helped by strong performance in its medical unit even as the drug distributor continues to face declining generic drug prices.

May 01 2017

UPDATE 1-Cardinal Health quarterly profit ahead of estimates

May 1 Cardinal Health Inc reported a better-than-expected quarterly profit, helped by strong performance in its medical unit even as the drug distributor continues to face declining generic drug prices.

May 01 2017

BRIEF-Cardinal Health Q3 non-gaap EPS $1.53

* Cardinal health reports third-quarter results for fiscal year 2017

May 01 2017

Cardinal Health quarterly revenue rises 3.8 pct

May 1 Cardinal Health Inc reported a 3.8 percent rise in quarterly revenue, helped by strength in its pharmaceutical business even as the drug distributor faces declining generic drug prices.

May 01 2017

LPC: US healthcare lending rouses from policy-induced sedation

NEW YORK US drug distributor Cardinal Health Inc’s deal to buy Medtronic Plc’s medical supplies units days after Abbott Laboratories agreed to a long-awaited purchase of diagnostic testing company Alere Inc has raised the pulse of a sector suppressed by potential healthcare policy upheaval.

Apr 20 2017

LPC: U.S. healthcare lending rouses from policy-induced sedation

NEW YORK U.S. drug distributor Cardinal Health Inc’s deal to buy Medtronic Plc’s medical supplies units days after Abbott Laboratories agreed to a long-awaited purchase of diagnostic testing company Alere Inc has raised the pulse of a sector suppressed by potential healthcare policy upheaval.

Apr 20 2017

LPC: US healthcare lending rouses from policy-induced sedation

NEW YORK, April 20 US drug distributor Cardinal Health Inc’s deal to buy Medtronic Plc’s medical supplies units days after Abbott Laboratories agreed to a long-awaited purchase of diagnostic testing company Alere Inc has raised the pulse of a sector suppressed by potential healthcare policy upheaval.

Apr 20 2017

Deals of the day-Mergers and acquisitions

April 18 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Tuesday:

Apr 18 2017

More From Around the Web

Competitors

Earnings vs. Estimates